-
Clinical collaboration between Prelude Therapeutics and MSD to evaluate the combined effect of PRT3789 and KEYTRUDA
On July 9th, Prelude Therapeutics, a precision oncology company in the clinical stage, announced the signing of a clinical trial cooperation and supply agreement with MSD. According to the terms of t ... -
Mosha Dongliang Xiangjin Expo showcases innovative achievements in all aspects
On November 5th, at the Merck Dongliang Xiangjin Expo, the company showcased outstanding achievements in innovative drugs, research pipelines, industrial cooperation, social responsibility, digitaliz ...